PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma.

Onco Targets Ther · 2013 · PMC3652562 · PMID 23674897

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Patients harboring PIK3CA -mutated lung adenocarcinoma showed a marginally significant shorter median PFS of 12 months (0–42 months) compared with patients with PIK3CA wildtype tumors, for whom median PFS was about 20 months (1–47 months).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.